Patient compliance with antimicrobial drugs: A Chinese survey

Tong, Shuangmei; Pan, Jiaqian; Shan, Lu; Tang, Jing

doi:10.1016/j.ajic.2018.01.008

Cited by 43 publications

(47 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…12 Another survey conducted in China demonstrated that nearly 87% of patients showed non -compliance with use of antibiotics and did not follow the complete course as prescribed. 13 This is in contrast with the results of our study where 26% did not follow the complete course. Possible reasons for non-compliance include fear of adverse effects caused by long term use, improvement in symptoms and complexity of the treatment.…”

Section: Discussioncontrasting

confidence: 90%

“…Possible reasons for non-compliance include fear of adverse effects caused by long term use, improvement in symptoms and complexity of the treatment. 13 In terms of practice, the role of pharmacies needs to be mentioned. They have an important role in contributing to public knowledge about appropriate antibiotic usage, as more fractions of the respondents stated that they obtained information on antibiotic use from pharmacies rather than from doctors.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Knowledge and Awareness Regarding Antibiotic usage and Resistance among General Population in Delhi-NCR Region

Sharma¹,

Sachdeva²,

Bhateja³

et al. 2019

IJMEDPH

View full text Add to dashboard Cite

Aim: To assess the knowledge and awareness related to antibiotic usage and resistance amongst general population. Materials and Methods: A total of one thousand citizens (of age group 25 -65 years) from Delhi-NCR participated in this study. A questionnaire survey comprising of ten questions relating to knowledge and awareness of antibiotic usage were completed by the participants. Results: It was observed that 74% of people rarely used antibiotics. Also, 55% believed that misuse/overuse of anti-microbial drugs is harmful and can have adverse effects on our body. A large fraction comprising of about 60% are affected by infections on a yearly basis. Conclusion: A majority of the population of our community believed in using antibiotics without having the necessary knowledge and awareness regarding its proper use.

show abstract

Section: Discussioncontrasting

confidence: 90%

Section: Discussionmentioning

confidence: 99%

Knowledge and Awareness Regarding Antibiotic usage and Resistance among General Population in Delhi-NCR Region

Sharma¹,

Sachdeva²,

Bhateja³

et al. 2019

IJMEDPH

View full text Add to dashboard Cite

show abstract

“…1 Incorrect use and abuse of antimicrobial agents are key drivers for the spread of antimicrobial drug resistance. [2][3][4][5] Frequent and prolonged use of broad-spectrum antimicrobial agents has been associated with the emergence of antimicrobial resistance. [6][7][8] Drug therapy problem (DTP) is any undesirable event experienced by a patient related to drug therapy, which interferes with achieving the desired goals of the pharmacological intervention.…”

Section: Introductionmentioning

confidence: 99%

<p>Antimicrobial Drug Therapy Problems Among Patients in the Outpatient Department of Ataye Hospital, Northeast Ethiopia</p>

Kassahun

Ayfokru

2020

IDR

View full text Add to dashboard Cite

Background: Antimicrobial drug therapy problems refer to incorrect and inappropriate utilization of antimicrobials which affect patient's health outcomes and results in bacterial resistance. Incorrect use of antimicrobial agents is a key driver for the spread of antimicrobial drug resistance. Improving drug therapy problems has an important effect on the patients' health, treatment costs, and enhancing patients' quality of life. Hence, the aim of the present study was to assess antimicrobial drug therapy problems among patients in the Outpatient Department of Ataye hospital, Northeast Ethiopia. Methods: A hospital-based retrospective cross-sectional study design was used to assess antimicrobial drug therapy problems among patients in Ataye hospital from September 2018 to February 2019. Data were collected by trained graduating pharmacy students by reviewing medical records of patients using checklists and questionnaires. Results: A total of 248 patient cards were included in this study. At least one antimicrobial drug therapy problem had occurred among 96 (38.7%) of the study participants. The most common drug therapy problem was the need for additional drug therapy which was incurred by 38 (15.3%) of the study participants and ineffective antimicrobial therapy was experienced by 22 (8.9%) of the patients. Tetracyclines 25 (26%), fluoroquinolones 19 (19.8%), and penicillins 18 (18.8%) were the most common classes of antimicrobials prone to drug therapy problems. Conclusion: The current study revealed that nearly two-fifths of the study participants had experienced at least one form of antimicrobial drug therapy problem. The most common drug therapy problem was the need for additional drug therapy and the use of ineffective antimicrobial therapy. Tetracyclines, fluoroquinolones, and penicillins were the main classes of antimicrobials involved in the drug therapy problem.

show abstract

“…In general, these ATC markets exhibit greater rates of non-adherence and shorter treatment periods than ATC N. Two recent studies (Fernandes et al, 2014 andTong et al, 2018) place the non-adherence rates for antimicrobial therapies at greater than 57 percent. In Appendix Table 15 we find a decline in aggregate demand of 24.2 percent (Model 1).…”

Section: Heterogeneity Across Therapeutic Marketsmentioning

confidence: 99%

Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling

Higgins¹,

Yan

Chatterjee

2021

Research Policy

View full text Add to dashboard Cite

We provide causal evidence that regulation induced product shocks significantly impact aggregate demand and firm performance in pharmaceutical markets. Event study results suggest an average loss between $569 million and $882 million. Affected products lose, on average, $186 million over their remaining effective patent life. This leaves a loss of between $383 million and $696 million attributable to declines in future innovation. Our findings complement research that shows drugs receiving expedited review are more likely to suffer from regulation induced product shocks. Thus, it appears we may be trading off quicker access to drugs today for less innovation tomorrow. Results remain robust to variation across types of relabeling, market sizes, and levels of competition.

show abstract

Patient compliance with antimicrobial drugs: A Chinese survey

Abstract: A range of factors were associated with compliance to antimicrobial therapy, including understanding of the treatment, gender, age, home address, education level, and family income.

Cited by 43 publications

References 24 publications

Knowledge and Awareness Regarding Antibiotic usage and Resistance among General Population in Delhi-NCR Region

Knowledge and Awareness Regarding Antibiotic usage and Resistance among General Population in Delhi-NCR Region

<p>Antimicrobial Drug Therapy Problems Among Patients in the Outpatient Department of Ataye Hospital, Northeast Ethiopia</p>

Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling

Contact Info

Product

Resources

About